Leading drug makers to face cancellation of product registrations.

Published: 2006-10-04 06:59:00

Updated: 2006-10-04 06:59:00

Due to the credibility problems of the bio equivalency test data quite a number of local top drug makers may encounter with the registration cancellation of their products.

The KFDA has found that more than half of the bio equivalency test problems were the cases reported by Labfrontier, a lea...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK